Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about disclosure

25 Jun 2021 Evaluate

Aurobindo Pharma has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 25, 2021 for Kambam Spoorthi.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1807.35
Dr. Reddys Labs. 1361.50
Cipla 1375.50
Lupin 2016.15
Zydus Lifesciences 1244.00
View more..